SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-24-008551
Filing Date
2024-01-16
Accepted
2024-01-16 16:04:53
Documents
12
Period of Report
2024-01-16
Items
Item 2.02: Results of Operations and Financial Condition

Document Format Files

Seq Description Document Type Size
1 8-K d110116d8k.htm   iXBRL 8-K 25240
  Complete submission text file 0001193125-24-008551.txt   146230

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA alec-20240116.xsd EX-101.SCH 2838
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE alec-20240116_lab.xml EX-101.LAB 17994
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE alec-20240116_pre.xml EX-101.PRE 11253
6 EXTRACTED XBRL INSTANCE DOCUMENT d110116d8k_htm.xml XML 3328
Mailing Address 131 OYSTER POINT BLVD., SUITE 600 SOUTH SAN FRANCISCO CA 94080
Business Address 131 OYSTER POINT BLVD., SUITE 600 SOUTH SAN FRANCISCO CA 94080 415-231-5660
Alector, Inc. (Filer) CIK: 0001653087 (see all company filings)

IRS No.: 822933343 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38792 | Film No.: 24535168
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)